Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.22%68.981.0%$928.57m
AMGNAmgen Inc.
-0.34%172.020.8%$653.23m
BIIBBiogen Inc.
-1.41%283.590.9%$519.54m
CELGCelgene Corporation
-1.22%117.821.0%$475.14m
REGNRegeneron Pharmaceuticals, Inc.
-2.92%359.431.9%$331.31m
ALXNAlexion Pharmaceuticals, Inc.
-1.36%129.052.0%$295.77m
TSROTESARO, Inc.
-3.34%183.6015.3%$189.37m
INCYIncyte Corporation
-1.81%119.162.3%$160.57m
ILMNIllumina, Inc.
-1.05%160.593.9%$142.93m
VRTXVertex Pharmaceuticals Incorporated
-1.48%84.522.6%$137.32m
EXELExelixis, Inc.
-2.56%22.045.5%$124.64m
CLVSClovis Oncology, Inc.
-4.04%58.7216.4%$122.49m
AAgilent Technologies, Inc.
-0.07%51.311.7%$116.26m
ACADACADIA Pharmaceuticals Inc.
0.05%39.1619.0%$93.54m
BMRNBioMarin Pharmaceutical Inc.
-0.78%89.094.0%$89.72m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.